Medicines: improving outcomes and value
Medicines value and access
Providing the commercial capabilities to enable the NHS in England to secure innovative treatments and everyday medicines that people rely on.
Medicines optimisation
Ensuring people get the right choice of medicines, at the right time, and are engaged in the process by their clinical team.
Biosimilar medicines
The NHS is working to increase the use of best value biological medicines, including biosimilar medicines.
Information for patients
Get details on where to go if you need some help or support with your medicines.
Support for prescribers
Expert advice and services to help prescribers to make informed decisions and put patients’ needs first.
Resources
Find tools and resources for prescribers, pharmacists and procurement leads.
You may also be interested in
- Repurposing medicines in the NHS in England
- Commercial medicines
- Medicines optimisation dashboard
- National medicines optimisation opportunities 2023/24
- Regional arrangements for medicines optimisation
- Items which should not be routinely prescribed in primary care: consultation
- Guidance on conditions for which over the counter items should not routinely be prescribed in primary care
News and blogs
Personalised ‘living drug’ to offer “hope of cure” for aggressive leukaemia on NHS
Patients with an aggressive form of leukaemia will be able to receive a breakthrough immunotherapy on the NHS that saw over three quarters of patients go into remission in trials. The CAR T-cell therapy – known as ‘obe-cel’ – involves taking a patient’s immune cells and reprogramming them in a lab to identify and target […]